These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25953004)

  • 1. Patterns of Lipid Lowering Therapy among Children Ages 8-20 Years.
    Joyce N; Wellenius GA; Dore DD; Newburger JW; Zachariah JP
    J Pediatr; 2015 Jul; 167(1):113-9.e1. PubMed ID: 25953004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.
    McCrindle BW; Urbina EM; Dennison BA; Jacobson MS; Steinberger J; Rocchini AP; Hayman LL; Daniels SR; ; ;
    Circulation; 2007 Apr; 115(14):1948-67. PubMed ID: 17377073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010.
    Tuppin P; Ricci-Renaud P; de Peretti C; Fagot-Campagna A; Gastaldi-Menager C; Danchin N; Alla F; Allemand H
    Arch Cardiovasc Dis; 2013 May; 106(5):274-86. PubMed ID: 23769402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and predictors of medication adherence to lipid-lowering therapy in children aged 8 to 20 years.
    Joyce NR; Wellenius GA; Eaton CB; Trivedi AN; Zachariah JP
    J Clin Lipidol; 2016; 10(4):824-832.e2. PubMed ID: 27578113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
    Chopra I; Kamal KM; Candrilli SD; Kanyongo G
    Postgrad Med; 2014 Jan; 126(1):66-77. PubMed ID: 24393753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers.
    Maciejewski ML; Livingston EH; Kahwati LC; Henderson WG; Kavee AL; Arterburn DE
    Surg Obes Relat Dis; 2010; 6(6):601-7. PubMed ID: 20965791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cross sectional study of familial hypercholesterolemia in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis].
    Wang XN; Wang F; Ye P; Hu DY; Zhao SP; Wang YJ; Mu YM; Yan XW; Li ZQ; Wei YD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Jun; 49(6):564-571. PubMed ID: 34126723
    [No Abstract]   [Full Text] [Related]  

  • 8. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends in the consumption of lipid-lowering drugs in Finland.
    Martikainen J; Klaukka T; Reunanen A; Peura S; Wahlroos H
    J Clin Epidemiol; 1996 Dec; 49(12):1453-57. PubMed ID: 8970497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in lipid profiles among South Korean adults: 2005, 2008 and 2010 Korea National Health and Nutrition Examination Survey.
    Nam GE; Han K; Park YG; Choi YS; Kim SM; Ju SY; Ko BJ; Kim YH; Kim EH; Cho KH; Kim DH
    J Public Health (Oxf); 2015 Jun; 37(2):286-94. PubMed ID: 24573366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender disparities in lipid-lowering therapy among veterans with diabetes.
    Vimalananda VG; Miller DR; Palnati M; Christiansen CL; Fincke BG
    Womens Health Issues; 2011; 21(4 Suppl):S176-81. PubMed ID: 21724138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
    Chopra I; Kamal KM
    Hosp Pract (1995); 2014 Apr; 42(2):77-88. PubMed ID: 24769787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
    Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
    Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in cardiovascular risk factors among people with diabetes in a population based study, Health Survey for England 1994-2009.
    Samaranayaka S; Gulliford MC
    Prim Care Diabetes; 2013 Oct; 7(3):193-8. PubMed ID: 23685024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidities in overweight children and adolescents: do we treat them effectively?
    Reinehr T; Wiegand S; Siegfried W; Keller KM; Widhalm K; l'Allemand D; Zwiauer K; Holl RW
    Int J Obes (Lond); 2013 Apr; 37(4):493-9. PubMed ID: 23147116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis.
    Alibaz-Oner F; Koster MJ; Unal AU; Yildirim HG; Çikikçi C; Schmidt J; Crowson CS; Makol A; Ytterberg SR; Matteson EL; Direskeneli H; Warrington KJ
    Rheumatology (Oxford); 2017 Nov; 56(11):1939-1944. PubMed ID: 28968808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The direct and indirect costs among U.S. privately insured employees with hypogonadism.
    Kaltenboeck A; Foster S; Ivanova J; Diener M; Bergman R; Birnbaum H; Kinchen K; Swindle R
    J Sex Med; 2012 Sep; 9(9):2438-47. PubMed ID: 22738380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of lipid lowering medications among adults in the United States 1999-2006.
    Li M; Ong KL; Tse HF; Cheung BM
    Atherosclerosis; 2010 Feb; 208(2):456-60. PubMed ID: 19700160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study.
    Heinze G; Jandeck LM; Hronsky M; Reichardt B; Baumgärtel C; Bucsics A; Müllner M; Winkelmayer WC
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):90-9. PubMed ID: 26468002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).
    Zhao S; Wang Y; Mu Y; Yu B; Ye P; Yan X; Li Z; Wei Y; Ambegaonakr BM; Hu D;
    Atherosclerosis; 2014 Aug; 235(2):463-9. PubMed ID: 24950001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.